相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Subtoxic Concentrations of Hepatotoxic Drugs Lead to Kupffer Cell Activation in a Human In Vitro Liver Model: An Approach to Study DILI
Victoria Kegel et al.
MEDIATORS OF INFLAMMATION (2015)
3D bioprinting of tissues and organs
Sean V. Murphy et al.
NATURE BIOTECHNOLOGY (2014)
Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine
Beth Williamson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Multi-cell type human liver microtissues for hepatotoxicity testing
S. Messner et al.
ARCHIVES OF TOXICOLOGY (2013)
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Patricio Godoy et al.
ARCHIVES OF TOXICOLOGY (2013)
A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity
Radina Kostadinova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
In vitro models for liver toxicity testing
Valerie Y. Soldatow et al.
TOXICOLOGY RESEARCH (2013)
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Rui M. Tostoes et al.
HEPATOLOGY (2012)
Hepatic stellate cells require a stiff environment for myofibroblastic differentiation
Abby L. Olsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Layered patterning of hepatocytes in co-culture systems using microfabricated stencils
Cheul H. Cho et al.
BIOTECHNIQUES (2010)
Idiosyncratic Drug-Induced Liver Injury and the Role of Inflammatory Stress with an Emphasis on an Animal Model of Trovafloxacin Hepatotoxicity
Patrick J. Shaw et al.
TOXICOLOGICAL SCIENCES (2010)
Review article: diagnosis and treatment of non-alcoholic fatty liver disease
M. K. Oh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
Tissue engineering by self-assembly of cells printed into topologically defined structures
Karoly Jakab et al.
TISSUE ENGINEERING PART A (2008)
Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha
Patrick J. Shaw et al.
TOXICOLOGICAL SCIENCES (2007)
The third dimension bridges the gap between cell culture and live tissue
Francesco Pampaloni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Gene expression profiles during hepatic stellate cell activation in culture and in vivo
Samuele De Minicis et al.
GASTROENTEROLOGY (2007)
Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns
Hasan H. Otu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mitochondrial abnonnalities - A link to idiosyncratic drug hepatotoxicity?
Urs A. Boelsterli et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils
JF Waring et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Endothelial extracellular matrix - Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization
GE Davis et al.
CIRCULATION RESEARCH (2005)
Idiosyncratic liver injury: Challenges and approaches
PB Watkins
TOXICOLOGIC PATHOLOGY (2005)
Idiosyncratic toxicity: the role of toxicophores and bioactivation
DP Williams et al.
DRUG DISCOVERY TODAY (2003)
Inflammation and drug idiosyncrasy - Is there a connection?
RA Roth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Screening for the potential of a drug candidate to cause idiosyncratic drug reactions
J Uetrecht
DRUG DISCOVERY TODAY (2003)
Trovafloxacin hepatotoxicity
DA Lazarczyk et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Immunological principles of adverse drug reactions - The initiation and propagation of immune responses elicited by drug treatment
DJ Naisbitt et al.
DRUG SAFETY (2000)
Concordance of the toxicity of pharmaceuticals in humans and in animals
H Olson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2000)